epilepsy

Showing NaN - NaN of 64

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Epilepsy Trial in United States (USL261)

Terminated
  • Epilepsy
  • Tucson, Arizona
  • +15 more
Oct 8, 2019

Epilepsy Trial in Worldwide (USL261, Placebo)

Terminated
  • Epilepsy
  • Phoenix, Arizona
  • +89 more
Oct 8, 2019

Epilepsy Trial in Worldwide (USL261, Placebo)

Completed
  • Epilepsy
  • Phoenix, Arizona
  • +50 more
Oct 8, 2019

Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P, Placebo Control)

Completed
  • Epilepsy
  • Dravet Syndrome
  • Birmingham, Alabama
  • +37 more
Jul 11, 2019

Proof of Principle forDiagnostic Blood Test of Recurrent

Completed
  • Epilepsy
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 29, 2019

    Epilepsy Trial in United States (RNS® System)

    Completed
    • Epilepsy
    • RNS® System
    • Phoenix, Arizona
    • +32 more
    May 31, 2019

    Safety of Fycompa in Routine Clinical Care of Epilepsy

    Completed
    • Epilepsy
    • Phoenix, Arizona
    • +43 more
    Apr 10, 2019

    Epilepsy Trial in Belgium, Mexico, United States (Lacosamide)

    Completed
    • Epilepsy
    • Sacramento, California
    • +20 more
    Mar 18, 2019

    Epilepsy Phenome/Genome Project

    Completed
    • Epilepsy
    • +5 more
      • Birmingham, Alabama
      • +24 more
      Nov 9, 2018

      Epilepsy Trial in Philadelphia (Levetiracetam)

      Completed
      • Epilepsy
      • Philadelphia, Pennsylvania
        Drexel University College of Medicine, Dept of Neurology
      Sep 13, 2018

      Epilepsy Trial in Worldwide (Placebo, Brivaracetam)

      Completed
      • Epilepsy
      • Phoenix, Arizona
      • +41 more
      Sep 4, 2018

      Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P 20 mg/kg/day Dose, Placebo control)

      Completed
      • Epilepsy
      • Dravet Syndrome
      • GWP42003-P 20 mg/kg/day Dose
      • Placebo control
      • Miami, Florida
      • +21 more
      Jul 26, 2018

      Epilepsy Trial in United States (diazepam nasal spray)

      Terminated
      • Epilepsy
      • diazepam nasal spray
      • Phoenix, Arizona
      • +32 more
      Jul 27, 2018

      Epilepsy, Lennox-Gastaut Syndrome Trial in Netherlands, Poland, United States (GWP42003-P 20 mg/kg/day Dose, Placebo)

      Completed
      • Epilepsy
      • Lennox-Gastaut Syndrome
      • GWP42003-P 20 mg/kg/day Dose
      • Placebo
      • Tampa, Florida
      • +23 more
      Jul 26, 2018

      Epilepsy Trial in Worldwide (Lacosamide)

      Completed
      • Epilepsy
      • Alabaster, Alabama
      • +157 more
      Jun 20, 2018

      Epilepsy Trial in Worldwide (Lacosamide)

      Completed
      • Epilepsy
      • Alabaster, Alabama
      • +107 more
      Jun 20, 2018

      Epilepsy Trial in Worldwide (Eslicarbazepine acetate)

      Completed
      • Epilepsy
      • Eslicarbazepine acetate
      • Northport, Alabama
      • +121 more
      Jul 16, 2018

      Epilepsy Trial in United States (Intravenous Carbamazepine (IV CBZ))

      Completed
      • Epilepsy
      • Intravenous Carbamazepine (IV CBZ)
      • Phoenix, Arizona
      • +28 more
      Dec 14, 2017

      Postoperative Craniotomy Pain in Pediatric Patients

      Completed
      • Post Craniotomy Surgery
      • +4 more
        • Baltimore, Maryland
        • +2 more
        Dec 7, 2017

        Epilepsy Trial in Canada, United States (Progesterone Lozenges, Matched Placebo Lozenges)

        Completed
        • Epilepsy
        • Progesterone Lozenges
        • Matched Placebo Lozenges
        • Los Angeles, California
        • +14 more
        Jun 2, 2017

        Epilepsy Trial in United States (Diazepam)

        Completed
        • Epilepsy
        • Phoenix, Arizona
        • +3 more
        Feb 28, 2017

        Epilepsy Trial in United States (Lamotrigine)

        Completed
        • Epilepsy
        • Birmingham, Alabama
        • +62 more
        Nov 30, 2016

        Epilepsy, Epilepsy, Partial Trial in Worldwide (LAMICTAL extended-release)

        Completed
        • Epilepsy
        • Epilepsy, Partial
        • LAMICTAL extended-release
        • Anniston, Alabama
        • +147 more
        Dec 2, 2016

        Epilepsy Trial in Worldwide (Eslicarbazepine acetate 1600 mg, Eslicarbazepine acetate 1200 mg)

        Completed
        • Epilepsy
        • Eslicarbazepine acetate 1600 mg
        • Eslicarbazepine acetate 1200 mg
        • Tucson, Arizona
        • +61 more
        Sep 13, 2016

        Epilepsy Trial in United States (lamotrigine extended-release)

        Completed
        • Epilepsy
        • lamotrigine extended-release
        • Anniston, Alabama
        • +11 more
        Sep 22, 2016